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Abstract
Background: The Neurocan-cartilage intermediate layer protein 2 (NCAN-CILP2) region forms a tight linkage
disequilibrium (LD) block and is associated with plasma lipid levels and non-alcoholic fatty liver disease (NAFLD) in
individuals of European descent but not in the Malay and Japanese ethnic groups. Recent genome-wide
resequence studies identified a missense single-nucleotide polymorphism (SNP) (rs58542926) of the transmembrane
6 superfamily member 2 (TM6SF2) gene in the NCAN-CILP2 region related to hepatic triglyceride content. This study
aims to analyze the influences of SNPs in this region on NAFLD and plasma lipid levels in the Asian and Pacific
ethnic groups and to reveal the reasons behind positive and negative genetic associations dependent on ethnicity.
Methods: Samples and characteristic data were collected from 3,013 Japanese, 119 Palauan, 947 Mongolian, 212
Thai and 401 Chinese people. Hepatic sonography data was obtained from the Japanese individuals. Genotyping
data of five SNPs, rs58542926, rs735273, rs1009136, rs1858999, and rs16996148, were used to verify the effect on
serum lipid levels by multiple linear regression, and the association with NAFLD in the Japanese population was
examined by logistic regression analysis.
Results: rs58542926 showed significant association with the plasma triglyceride (TG) level in Japanese (P = 0.0009,
effect size = 9.5 (±3.25) mg/dl/allele) and Thai (P = 0.0008, effect size = 31.6 (±11.7) mg/dl/allele) study subjects. In
Mongolian individuals, there was a significant association of rs58542926 with total cholesterol level (P = 0.0003,
11.7 (±3.2) mg/dl/allele) but not with TG level. In multiple comparisons in Chinese individuals, rs58542926 was
weakly (P = 0.022) associated with TG levels, although the threshold for statistical significance was not reached.
In Palauan individuals, there was no significant association with the studied SNPs. rs58542926 also showed
significant association with Japanese NAFLD. The minor allele (t) increased NAFLD risk (OR 1.682, 95 % CI 1.289–2.196,
p value 0.00013).
Conclusion: This study confirmed the genetic association of missense SNP of TM6SF2, rs58542926, with plasma lipid
levels in multiple East Asian ethnic groups and with NAFLD in Japanese individuals.
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Background
Dyslipidemia, which refers to abnormally high or low lipid
levels in circulating blood, is a major heritable risk factor
of cardiovascular and cerebrovascular diseases. Many
studies have investigated genetic factors of plasma lipid
levels to explore the responsible metabolic pathways.
Through genome-wide association studies (GWAS), abun-
dant genetic variants associated with plasma lipid levels
have been identified, among which the Neurocan-cartilage
intermediate layer protein 2 (NCAN-CILP2) region has
high statistical significance and a relatively large effect size
per allele on low-density lipoprotein cholesterol (LDL)
and triglyceride (TG) levels [1, 2]. The NCAN-CILP2 re-
gion spans 300 kb on chromosome 19 and forms a tight
linkage disequilibrium (LD) block. Eleven genes and
one miRNA are encoded in this region. This locus
showed consistent and deep association with serum
lipid levels in the subsequent studies for individuals
of European and Chinese descent [3–5]. However, the
tag SNP in this region, rs16996148, was not corre-
lated with plasma lipids in Malaysian [6] and Japanese
populations [7, 8].
In addition to plasma lipid levels, the NCAN-CILP2
region was identified as a non-alcoholic fatty liver dis-
ease (NALFD)–associated locus by GWAS in individuals
of European descent [9] but not in Japanese individuals
[10, 11]. The risk allele for NAFLD in this region de-
creased plasma lipid levels in individuals of European
descent [9]. Recent genome-wide resequence studies
identified a missense single-nucleotide polymorphism
(SNP) (rs58542926) in transmembrane 6 superfamily
member 2 (TM6SF2), which is related to hepatic trigly-
ceride content [12, 13]. Functional assessment of Tm6sf2
in mouse and human hepatocytes revealed that it regu-
lated plasma TG and cholesterol levels in mice and lipid
accumulation in hepatocytes [12–14].
a
b
Fig. 1 a Pairwise linkage disequilibrium analysis of the five studied SNPs in the NCAN-CILP2 region in European (CEU), Japanese, Chinese,
Mongolian, Thai and Palauan individuals. Numerals in the left-lower diagonal show |D’| values and in the right-upper diagonal half show
r2 values. b Haplotype frequencies in the five studied populations and referential CEU population. The chart on the right shows the
estimated haplotypes in the order of rs58542926, rs735273, rs1009136, rs1858999 and rs16996148. Capital letters indicate major alleles,
and small letters indicate minor alleles
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rs16996148 and rs58542926 are on opposite sides of
the LD block. There was no significant difference in LD
structure between European and Japanese populations in
the HapMap database (http://hapmap.ncbi.nlm.nih.gov/).
The present study aims to analyze the influences of
SNPs in this region on NAFLD and plasma lipid levels
in Asian and Pacific ethnic groups and to reveal the rea-
sons behind positive and negative genetic correlations
dependent on ethnicity.
Results
Genetic association of NCAN-CILP2 region with East Asian
plasma lipid levels
Genotyping success rates were >97 % for all of the SNPs.
There were no deviations from Hardy-Weinberg equilib-
rium for any of the SNPs in all ethnic groups (P > 0.05).
Details of all 5 SNPs and minor allele frequencies
(MAFs) for each population are described in Table 1.
rs58542926 showed significant associations with plasma
lipid levels in multiple ethnic groups, which persisted
after applying the Bonferroni correction for multiple
testing (5 SNPs and 4 phenotypes). In Japanese individ-
uals, rs58542926 was strongly associated with TG level.
The minor allele (t) decreased the TG level by 9.5
(±3.25) mg/dl/allele. rs58542926, rs735273, rs1009136
and rs1858999 were weakly associated with TG level in
Chinese individuals, but the associations did not reach
the statistical significance threshold. In Mongolian indi-
viduals, a significant association of rs58542926 was ob-
served with total cholesterol and LDL level, but not with
TG level. The minor allele decreased total cholesterol by
11.7 (±3.2) mg/dl/allele and LDL cholesterol by 8.3
(±2.9) mg/dl/allele. However, the minor allele solely de-
creased the TG level in Thai individuals by 31.6 (±11.7)
mg/dl/allele. In Palauan individuals, there were no signifi-
cant associations with the studied SNPs. In combined ana-
lysis, the association of rs58542926 with total cholesterol
and TG levels becomes further significant. These results
support the previous data that the studied missense SNP in
TM6SF2 is the functional SNP in the NCAN-CILP2 region.
Genetic association of the NCAN-CILP2 region with
Japanese NAFLD
Among the studied SNPs, rs58542926 showed the most
significant association with Japanese NAFLD. The minor
allele (t) increased NAFLD risk (OR 1.682, 95 % CI 1.289–
2.196, p value 0.00013) (Table 2). The allele that reduced
plasma lipid levels was the risk allele for NAFLD.
Haplotype frequency and linkage disequilibrium
structures
To evaluate the LD structure of NCAN-CILP2 in the
Asian and Pacific populations, a pairwise linkage dis-
equilibrium map was drawn for each ethnic group, and
the maps were compared with |D’| and r2 values of the
CEU population downloaded from the HapMap database
(Fig. 1a). The middle three SNPs, rs735273, rs1009136,
and rs1858999, showed relatively high r2 values in all of
the ethnic groups. But, the most telomeric side SNP,
rs58542926, showed weak LD with the middle LD block,
even though the physical distance between rs58542926
and rs735273 was close, 5.8 kb, and they showed a high
|D’| value, indicating rare recombinations between them.
Conversely, the most centromeric side SNP, rs16996148,
showed a moderate r2 score with rs58542926, despite
the long distance between them, 289 kb. The r2 score
between rs58542926 and rs16996148 in the CEU popula-
tion was relatively high. The estimated haplotype fre-
quency showed a higher prevalence of the haplotype
encoding the NAFLD risk allele in the Palauan individ-
uals as compared to other ethnic groups (Fig. 1b). Hap-
lotypes carrying minor allele (t) of rs16996148 in the
CEU population mostly (94.7 %) encoded as minor allele
(t) of rs58542926, but in the Japanese, Mongolian, Thai
and Palauan populations, substantial haplotypes (21.5–
37.1 %) encoded major allele (C) of rs58542926 with (t)
of rs16996148.
Discussion
This study replicated the genetic association of a mis-
sense SNP in TM6SF2 with plasma lipid levels in mul-
tiple ethnic groups, while the other four SNPs did not
show significant associations. Lysine at residue 167 in
TM6SF2 reduced TG but did not reduce cholesterol in
the plasma of Japanese and Thai individuals. In Mongolian
individuals, rs58542926 reduced total cholesterol but not
TG. Despite the higher minor allele frequency in Palauan
individuals, rs58542926 was not associated with lipid
levels. A small population size was considered as the main
cause of the lack of association, but other ethnic-specific
factors could have affected the results (e.g., relatively
higher prevalence of type 2 diabetes (20.2 %) and obesity
(87.8 %, body mass index (BMI) > 25)) in the Palauan
population [15]. Population-dependent preference to asso-
ciated lipid fraction was also observed in previous studies.
Norwegians showed association only with total choles-
terol, [12] but European Americans showed over 400-fold
smaller p value with TG than LDL cholesterol [13]. The
Hispanic group did not show any significant association
with lipid levels [13]. These results suggest that the regula-
tion of cholesterol and TG in plasma by TM6SF2 is af-
fected by ethnicity. The variable effect of rs58542926 on
plasma lipid profiles may be feasibly explained by differ-
ences in dietary fat or neutraceutical intake [16] according
to ethnic tradition.
This study also replicated the genetic association of
TM6SF2 with NAFLD in Japanese. The lysine allele of
rs58542926 increased the risk diagnosed of a bright liver
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in ultrasonography. Although the exact biochemical
function of TM6SF2 protein has not yet been revealed,
knocking down of Tm6sf2 expression in mouse liver re-
duced cholesterol and TG levels in mouse plasma and
increased hepatic lipid droplet content [12, 13]. In
human hepatocyte cell lines, disturbed expression of
TM6SF2 reduced VLDL excretion and increased cyto-
plasmic lipid droplets [14]. Furthermore, amino acid
substitution at residue 167 from glutamine to lysine di-
minished the protein level in the endoplasmic reticulum
membrane of the transfected cells, probably via mis-
folded protein degradation [13]. Therefore, it was
suggested that TM6SF2 protein is involved in lipid
Table 2 Association study of SNPs in NCAN-CILP2 region with
NAFLD in Japanese individuals
dbSNP ID (nearest gene) OR (95%CI) p value
rs58542926 (TM6SF2) 1.682 (1.289–2.196) 0.001
rs735273 (TM6SF2) 1.290 (1.093–1.522) 0.003
rs1009136 (MAU2) 1.251 (1.060–1.478) 0.008
rs1858999 (GATAD2A) 1.199 (1.015–1.417) 0.033
rs16996148 (CILP2) 1.186 (0.943–1.493) 0.145
Odd ratio (OR) and P value of each minor allele in the logistic regression
model are shown











MAF (P-HWE) 0.080 (0.858) 0.0682 (0.787) 0.078 (0.707) 0.114 (0.227) 0.237 (0.663)
β P value β P value β P value β P value β P value β P value
TM6SF2 total cholesterol −0.035 0.048 −0.089 0.0835 −0.116 0.0003* −0.095 0.157 0.012 0.907 −0.051 0.0005*
E167K LDL −0.027 0.130 −0.041 0.4276 −0.091 0.005 −0.077 0.258 0.077 0.454 −0.030 0.039
C/t HDL 0.005 0.747 0.0265 0.5837 −0.018 0.551 0.107 0.109 −0.128 0.195 −0.007 0.600
Log TG −0.054 0.0009* −0.109 0.0224 −0.030 0.334 −0.222 0.0008* −0.023 0.813 −0.056 3.15×10-5*
rs735273 MAf (P-HWE) 0.291 (0.719) 0.277 (0.613) 0.351 (0.788) 0.342 (0.151) 0.572 (0.966)
chr19:19274602 β P value β P value β P value β P value β P value β P value
TM6SF2 total cholesterol 0.008 0.674 −0.091 0.071 −0.034 0.293 −0.018 0.787 −0.049 0.639 −0.030 0.036
5’ flanking LDL −0.005 0.793 −0.019 0.700 0.001 0.986 0.024 0.724 −0.008 0.936 −0.019 0.181
T/c HDL 0.037 0.019 −0.017 0.728 −0.038 0.211 0.024 0.721 −0.048 0.635 −0.005 0.716
Log TG −0.025 0.128 −0.098 0.038 −0.019 0.544 −0.147 0.028 −0.052 0.599 −0.031 0.019
rs1009136 MAF (P-HWE) 0.286 (0.757) 0.275 (0.706) 0.341 (0.911) 0.347 (0.128) 0.572 (0.966)
chr19:19329619 β P value β P value β P value β P value β P value β P value
MAU2 total cholesterol 0.008 0.663 −0.088 0.084 −0.042 0.186 −0.019 0.783 −0.049 0.693 −0.030 0.041
intronic LDL −0.005 0.793 −0.005 0.915 −0.001 0.977 0.021 0.755 −0.008 0.936 −0.016 0.275
G/a HDL 0.038 0.018 −0.009 0.855 −0.041 0.178 0.036 0.590 −0.048 0.635 −0.005 0.719
Log TG −0.026 0.113 −0.094 0.047 −0.031 0.313 −0.148 0.027 −0.058 0.599 −0.035 0.010
rs1858999 MAF (P-HWE) 0.276 (0.844) 0.253 (0.349) 0.335 (0.422) 0.370 (0.168) 0.5812 (0.994)
chr19:19386860 β P-value β P-value β P-value β P-value β P-value β P-value
GATAD2A total cholesterol −0.003 0.853 −0.098 0.054 −0.047 0.139 −0.023 0.729 −0.053 0.610 −0.037 0.012
intronic LDL −0.019 0.289 −0.003 0.946 0.000 0.997 −0.008 0.909 −0.010 0.927 −0.022 0.121
G/c HDL 0.046 0.004 0.008 0.866 −0.031 0.308 0.035 0.594 −0.067 0.501 0.001 0.997
Log TG −0.044 0.007 −0.110 0.021 −0.027 0.380 −0.112 0.096 −0.060 0.541 −0.042 0.002*
rs16996148 MAF (P-HWE) 0.119 (0.470) 0.069 (0.611) 0.099 (0.907) 0.132 (0.631) 0.308 (0.854)
chr19:19547663 β P value β P value β P value β P value β P value β P value
CILP2 total cholesterol −0.034 0.057 −0.049 0.336 −0.092 0.004 −0.106 0.116 0.024 0.820 −0.032 0.026
3’ flanking LDL −0.032 0.069 0.005 0.923 −0.073 0.024 −0.094 0.166 0.123 0.238 −0.016 0.276
G/t HDL 0.009 0.554 0.030 0.538 −0.049 0.106 0.091 0.171 −0.080 0.421 0.001 0.948
Log TG −0.038 0.020 −0.065 0.175 −0.007 0.817 −0.181 0.007 −0.058 0.552 −0.037 0.006
Beta coefficient (β) and P values of copy numbers of minor alleles for each lipid parameter in multiple linear regression models of the indicated ethnic groups are
shown. Minor alleles of each SNP are indicated by lowercase letters. Statistical significance is shown by an asterisk (*) on the threshold of <0.0025. MAF (P HWE):
minor allele frequency (P value of Hardy-Weinberg equilibrium.)
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transportation through the ER membrane. Our genetic re-
sults support the theory that the SNP induced a change of
the physiological function of the TM6SF2 gene.
rs16996148 was initially identified as an SNP associ-
ated with plasma cholesterol and TG in a population of
European descent [2]. However, this finding was not rep-
licated in Japanese individuals [7]. The LD score between
rs16996148 and rs58542926 in the CEU population was
more rigid than in East Asian populations, due to the
low frequencies of Ccact and CTGct haplotypes. This
distinct LD structure and haplotype frequencies in East
Asian populations may have resulted in the lack of asso-
ciation. The haplotype frequency in our studied ethnic
groups suggested that the functional SNP in TM6SF2,
rs58542926, emerged in the haplotype encoding minor
alleles at the remaining four SNPs. It was intriguing that
the minor allele haplotype was highly prevalent in
Palauan individuals as compared to other ethnic groups.
Although rs58542926 is a risk allele for NAFLD, it has
been reported to be beneficial for CAD [12, 17]. The
NCAN-CILP2 region was also suspected to be a type 2
diabetes–associated locus [18], although the pathogenic
locus has not been identified. One explanation for these
observations may be that the NAFLD risk allele was dra-
matically increased in the ancestors of Palauan individ-
uals by natural selection, which would be related to
energy metabolism. The NAFLD risk allele may be asso-
ciated with a phenotype that stores excessive energy in
the liver and might be advantageous under conditions
of highly restricted food availability. Further popula-
tion genetic studies are required to determine if the
higher prevalence of the Lys167 allele in the Palauan
population is a consequence of natural selection or
simple genetic drift.
Conclusion
In conclusion, our study replicated the genetic associ-
ation of missense SNP of TM6SF2, rs58542926, with
plasma lipid levels in East Asian multiple ethnic groups.
While associated lipid, cholesterol, or TG levels were
dependent on ethnicity, the effect sizes were relatively
large. The SNP was also associated with Japanese
NAFLD. These results support previous genetic studies
and can be used to estimate the physiological function
of TM6SF2, which could be a personal biomarker for
medical management of dyslipidemia and NAFLD.
Methods
Study populations
The present study design was approved by the ethical
committee of Jichi Medical University and Kagawa
Nutrition University. All participants provided written
informed consent. Samples were collected from 3,013
Japanese, 119 Palauan, 947 Mongolian, 212 Thai and
401 Chinese people. Population characteristics have been
previously described [15, 19]. Participant age, sex, alco-
hol consumption (obtained by self-questionnaire), body
mass index (BMI), and levels of plasma triglyceride
(TG), total cholesterol, low-density lipoprotein choles-
terol (LDL), and high-density lipoprotein cholesterol
(HDL-c) (mg/dl) were collected. Hepatic sonography data
were simultaneously obtained in Japanese samples for fatty
liver evaluation, which was examined by an experienced
clinical technologist and reviewed by clinicians.
Genotyping and association analysis
The following five SNPs of the NCAN-CILP2 LD block
were chosen considering the LD structure of the Japanese
population and the results of recent studies [9–13]:
rs58542926 (most adjacent gene; TM6SF2), rs735273
(TM6SF2), rs1009136 (MAU2), rs1858999 (GATAD2A),
and rs16996148 (CILP2). All five SNPs were genotyped by
the TaqMan Genotyping Assay Systems (Applied Biosys-
tems, Foster City, CA, USA). Multiple linear regression
analysis was employed to calculate the effect of each
minor allele on four serum lipid concentration levels: TG,
total cholesterol, LDL, and HDL. The analysis was calcu-
lated separately in each ethnic group. Age, sex, and BMI
were included for adjustment as covariant factors. Trigly-
ceride levels were transformed to logarithm to reduce the
overestimated effect from skewed distribution, but un-
transformed values of triglycerides were also assessed
for the purpose of showing an effect size of SNPs. To
study the association of these five SNPs and NAFLD
in the Japanese population, participants who had ex-
cessive alcohol consumption (>20 g/day) history were
excluded. Then, genotyping results of 2,281 of the
3,013 Japanese DNA panels were studied. Logistic re-
gression analysis was applied with adjustments for
age, sex, BMI, and type 2 diabetes mellitus (DM2).
All statistical analyses were performed with SPSS soft-
ware. Haplotype frequencies for each population were
calculated, and LD blocks were drawn by Haploview
software [20].
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